Venture Life Group plc (AIM: VLG)
London flag London · Delayed Price · Currency is GBP · Price in GBX
39.90
-1.10 (-2.68%)
Nov 20, 2024, 5:05 PM GMT+1

Venture Life Group Company Description

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally.

The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids.

It also provides dermatology products comprising Myco Clear, a fungal nail cleanser and solution brand; Rosa calma for normalizing and controlling the signs and symptoms related to rosacea; Bioscalin for the cosmetic treatment and prevention of hair loss, hair thinning, and baldness; and skincare solutions under the brand Lubatti.

In addition, the company offers women’s healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ brand.

Further, it provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos, as well as Glucogel for the treatment of hypoglycaemia.

Additionally, the company offers ENT care products comprising Earol, for the removal of ear wax; EarolSwim, an invisible ear plugs for protecting the ears from water ingress; Baby Earol, an ear spray for babies; and Sterinase for relieving blocked noses, clearing nasal passages, and preventing the risk of allergic reactions and infections.

It also provides oncology support products, such as Pomi-T, used for the management of prostate-specific antigen levels in prostate cancer; Gelclair, a muco-adhesive oral rinse for the treatment of Oral Mucositis; and Xonrid, a hyaluronic acid based topical gel, for the prevention and treatment of Radiation Induced Dermatitis.

The company was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.

Venture Life Group plc
Country United Kingdom
Founded 2005
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 165
CEO Jeremy Anthony Randall

Contact Details

Address:
12 The Courtyard
Bracknell, RG12 2XB
United Kingdom
Phone 44 13 4457 8004
Website venture-life.com

Stock Details

Ticker Symbol VLG
Exchange London Stock Exchange AIM
Fiscal Year January - December
Reporting Currency GBP
ISIN Number GB00BFPM8908
SIC Code 2834

Key Executives

Name Position
Jeremy Anthony Randall Chief Executive Officer
Daniel Wells Chief Financial Officer